文献速递银屑病与炎症性皮肤病自身免疫性与大疱性皮肤病

DLQI-R评分提升银屑病、天疱疮与硬斑病患者DLQI区分度

DLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea.
PubMed 文献 · Br J Dermatol · 2019-10-16

该横断面研究纳入637例硬斑病、天疱疮和银屑病患者,比较原版DLQI与DLQI-R评分的区分度。结果显示,在报告「不相关」应答的患者中,DLQI-R在多个条目及总分上绝对与相对信息量更高,可更准确量化健康相关生活质量,适用于临床与研究。

要点

  • DLQI-R评分利用「不相关」应答信息,提升问卷区分度。
  • 在硬斑病、天疱疮和银屑病患者中,DLQI-R总分信息量更高。
  • 已开发评分图表辅助医生使用DLQI-R评分。

核心结论

  • 在硬斑病、天疱疮和银屑病患者中,DLQI-R评分通过利用「不相关」应答的额外信息,提高了问卷的区分度。

研究设计与样本

  • 横断面研究,纳入637例硬斑病、天疱疮和银屑病患者,比较原版DLQI与DLQI-R评分的绝对和相对信息量。

主要发现

  • 在报告「不相关」应答的亚组(n=261,41%)中,三种疾病所有8个含「不相关」选项条目的绝对信息量均以DLQI-R更高。
  • DLQI-R在天疱疮、硬斑病和银屑病中分别有8、8和6个条目的相对信息量更优。
  • DLQI-R在总分≤20分的所有DLQI分数段中均提高了条目平均信息量。
  • 三种疾病的DLQI-R总分均显示更高的绝对和相对信息量。

临床怎么用

  • DLQI-R评分可用于临床实践和研究,更准确量化患者健康相关生活质量。
  • 已开发评分图表辅助医生进行DLQI-R评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Dermatology Life Quality Index (DLQI) rates 'not relevant' responses (NRRs) as the item on the questionnaire having no impact on the patients' lives at all. The DLQI-Relevant (DLQI-R) is a recently developed scoring that adjusts the total score of the questionnaire for the number of NRRs indicated by a patient. OBJECTIVES: To compare the discriminatory power of the original and DLQI-R scoring approaches in terms of absolute and relative informativity. METHODS: Cross-sectional data from 637 patients with morphea, pemphigus and psoriasis were used for the analyses. To assess absolute and relative informativity, Shannon's index and Shannon's evenness index were calculated for the 10 items on the questionnaire and for DLQI and DLQI-R total scores. RESULTS: Mean DLQI and DLQI-R scores of patients were 6·13 vs. 6·91. In the subset of patients with NRRs (n = 261, 41%), absolute informativity was higher with the DLQI-R scoring for all eight items with NRR options in all three conditions. The DLQI-R exhibited a better relative informativity in 8, 8 and 6 items in pemphigus, morphea and psoriasis, respectively. The DLQI-R led to an improvement in average item-level informativity in all DLQI score bands up to 20 points. Regarding total scores, the DLQI-R produced both a higher absolute and relative informativity in all three conditions. CONCLUSIONS: In patients with morphea, pemphigus and psoriasis, DLQI-R scoring improves the discriminatory power of the questionnaire by benefiting from the additional information in NRRs. DLQI-R scoring may be useful both in clinical practice and research. A scoring chart has been developed to aid physicians with scoring. What's already known about this topic? The original scoring of the Dermatology Life Quality Index (DLQI) rates 'not relevant' responses as the item of the questionnaire having no impact on the patients' lives at all. DLQI-Relevant (DLQI-R) is a new scoring developed in 2018 that adjusts the total score of the questionnaire for the number of 'not relevant' responses indicated by patients. The discriminatory power of the DLQI-R compared with the DLQI has not yet been investigated. What does this study add? In patients with psoriasis, pemphigus and morphea, DLQI-R scoring improves the discriminatory power of the questionnaire by benefiting from the additional information in 'not relevant' responses. What are the clinical implications of this work? DLQI-R scoring may help to more accurately quantify patients' health-related quality of life both in clinical practice and research. A scoring chart has been developed to aid physicians with scoring.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Rencz F, Gulácsi L, Péntek M, et al. DLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea. Br J Dermatol. 2019. PMID: 31419310. doi:10.1111/bjd.18435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。